Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Biological Sciences
  7. Microbiology
  9. Microbial Genetics
  11. The Quantification Of Drug Accumulation Within Gram-negative Bacteria

The Quantification of Drug Accumulation within Gram-Negative Bacteria

Amir George, Shivangi, Alexandra Bozan

    Biorxiv : the Preprint Server for Biology
    |June 12, 2025

    Related Experiment Videos

    Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
    08:23

    Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

    Published on: March 2, 2020

    12.6K
    Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
    08:04

    Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

    Published on: February 8, 2019

    8.6K
    Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli
    12:29

    Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli

    Published on: March 24, 2023

    1.9K

    View abstract on PubMed

    Summary
    This summary is machine-generated.

    A new method quantifies how drugs build up inside bacteria, impacting their effectiveness as antibacterial agents. This research aids in developing new antibacterial drugs and understanding drug resistance mechanisms.

    Area of Science:

    • Microbiology
    • Pharmacology
    • Biochemistry

    Background:

    • Intrabacterial drug accumulation influences small molecule interactions with bacteria.
    • This accumulation affects chemical probe utility and antibacterial drug efficacy.
    • Understanding drug accumulation is vital for antibacterial drug discovery.

    Purpose of the Study:

    • To present a general method for quantitatively interrogating intrabacterial drug accumulation and metabolism (IBDM).
    • To exemplify the method in Gram-negative bacteria, including *Escherichia coli*, *Acinetobacter baumannii*, *Klebsiella pneumoniae*, and *Pseudomonas aeruginosa*.
    • To adapt the method for both single-compound and high-throughput screening.

    Main Methods:

    • Developed a liquid chromatography-mass spectrometry (LC-MS) based platform for IBDM analysis.

    Related Experiment Videos

    Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
    08:23

    Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

    Published on: March 2, 2020

    12.6K
    Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
    08:04

    Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

    Published on: February 8, 2019

    8.6K
    Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli
    12:29

    Population and Single-Cell Analysis of Antibiotic Persistence in Escherichia coli

    Published on: March 24, 2023

    1.9K
  • The platform does not require drug labeling.
  • Applied in single-compound and high-throughput formats for various Gram-negative bacteria.

    • Main Results:

    • Demonstrated correlation between drug accumulation and minimum inhibitory concentration (MIC).
    • Showcased utility in wild-type and efflux-deficient *E. coli* strains.
    • Investigated drug synergy, revealing selective enhancement of drug accumulation.

    Conclusions:

    • The presented LC-MS platform provides a robust method for quantifying IBDM in Gram-negative bacteria.
    • The method correlates drug accumulation with antibacterial efficacy and aids in understanding resistance.
    • Validated high-throughput format is adaptable for screening assays in drug discovery and fundamental research.